+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Postoperative radiotherapy in early stage carcinoma of the uterine cervix: treatment results and prognostic factors



Postoperative radiotherapy in early stage carcinoma of the uterine cervix: treatment results and prognostic factors



Gynecologic Oncology 72(1): 10-15



The objective was to investigate the effect of pathologic parameters and other variables on treatment outcome for patients with International Federation of Gynecology and Obstetrics (FIGO) stage IB, IIA cervical carcinoma, as well as to assess the morbidities attributable to radical surgery combined with postoperative radiotherapy. Between January 1980 and June 1994, 179 women with FIGO stage IB, IIA carcinoma of the uterine cervix were treated with radical hysterectomy and postoperative irradiation. The median follow-up of alive patients was 6.8 years. All patients received 44-60 Gy external irradiation. One hundred fifty-nine patients received 3-10 Gy intracavitary brachytherapy. The data were analyzed for overall survival, disease-free survival, pelvic control, and treatment-related complications. The 5-year overall survival rate, disease-free survival rate, and pelvic control rate for the 179 patients were 72, 74, and 90%, respectively. The 5-year overall survival rate was 81% for patients without pelvic lymphadenopathy and 53% for those with pelvic lymphadenopathy (P = 0.0000). Other independent prognostic factors for overall survival included tumor differentiation and the interval between operation and initiation of radiotherapy. For the endpoint of disease-free survival, pelvic lymph node status, tumor differentiation, the duration of interruption of radiotherapy, and the interval between operation and radiotherapy were of independent prognostic significance. As pelvic control was concerned, the 5-year pelvic control rate was 90% and only the duration of interruption of radiotherapy was noted as an independent predictor of pelvic control. Distant metastases were noted in 43 patients (24%); the most common sites were lung (10%), liver (6%), and bone (6%). The overall 5-year intestinal and urinary complication-free rate was 66 and 82%, respectively. The overall incidence of grade 3 or above late rectal and urinary sequelae was 10%. For patients sustaining leg lymphedema after radiotherapy, there was higher incidence of severe leg cellulitis which warranted antibiotics treatment. These prognostic factors should be considered in patient counseling and treatment planning. Based on these factors, a more aggressive treatment to improve survival in these subsets of high-risk patients might be justified. New therapeutic regimens and modalities aimed to overcome treatment failure should be investigated.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 011174897

Download citation: RISBibTeXText

PMID: 9889023

DOI: 10.1006/gyno.1998.5217


Related references

Evaluation of treatment results and prognostic factors in early-stage cervical carcinoma patients treated with postoperative radiotherapy or radiochemotherapy. European Journal of Gynaecological Oncology 33(1): 62-67, 2012

Postoperative radiotherapy in carcinoma of the cervix: Treatment results and prognostic factors. Radiotherapy & Oncology 35(3): 198-205, 1995

Prognostic factors and treatment comparison in early-stage small cell carcinoma of the uterine cervix. Oncology Letters 3(1): 125-130, 2012

FIGO stage IIIB squamous cell carcinoma of the uterine cervix Natural history, treatment results, and prognostic factors. International Journal of Radiation Oncology Biology Physics 36(1 Suppl. ): 217, 1996

Definitive radiotherapy combined with high-dose-rate brachytherapy for stage III carcinoma of the uterine cervix: Retrospective analysis of prognostic factors concerning patient characteristics and treatment parameters. International Journal of Radiation Oncology Biology Physics 41(2): 319-327, 1998

Prognostic factors in women with early stage small cell carcinoma of the uterine cervix. Oncology Research 18(5-6): 279-286, 2009

Stage IIb, IIIb, and IVa carcinoma of the uterine cervix--results of treatment by radiotherapy in 649 patients. Neoplasma 34(3): 337-345, 1987

Cancer of uterine cervix stage IB. Treatment results and prognostic factors. Cancer 57(4): 866-870, 1986

Prognostic and treatment factors affecting local control of stage ib stage iia iib carcinoma of the intact uterine cervix treated with radiation therapy alone. International Journal of Radiation Oncology, Biology, Physics 8(Suppl. 1): 88, 1982

Postoperative radiotherapy for stage IB carcinoma of the uterine cervix. Yonsei Medical Journal 31(4): 367-374, 1990

The influence of selected prognostic factors on the results of combined treatment of invasive carcinoma of the cervix on stage IB and stage IIA. Ginekologia Polska 70(7): 484-489, 1999

Postoperative radiotherapy in the treatment of uterine sarcomas: long-term results and analysis of prognostic factors. Journal of BUON 15(3): 480-488, 2010

Results of treatment of early stage I carcinoma of the uterine cervix with intracavitary radium alone. Cancer 41(3): 980-985, 1978

Definitive radiation therapy in the treatment of carcinoma of the uterine cervix. Treatment results and prognostic factors. Strahlentherapie und Onkologie 167(11): 628-637, 1991

Postoperative radiotherapy in thymic carcinoma: Treatment results and prognostic factors. International Journal of Radiation Oncology Biology Physics 52(3): 801-805, 2002